CD8A and neoplasm: Stimulated by exogenous IFN-β, these cDC2 acquired and presented intact tumor-derived p-MHC class I complexes to induce CD8+ T cell-involved antitumor immunity against progressor tumors in mice lacking cDC1 188, 190.